321 related articles for article (PubMed ID: 36000310)
1. γδ T cell exhaustion: Opportunities for intervention.
Chen D; Guo Y; Jiang J; Wu P; Zhang T; Wei Q; Huang J; Wu D
J Leukoc Biol; 2022 Dec; 112(6):1669-1676. PubMed ID: 36000310
[TBL] [Abstract][Full Text] [Related]
2. Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy.
Bhat J; Placek K; Faissner S
Front Immunol; 2022; 13():894580. PubMed ID: 35669772
[TBL] [Abstract][Full Text] [Related]
3. A close look at current γδ T-cell immunotherapy.
Ma L; Feng Y; Zhou Z
Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
[TBL] [Abstract][Full Text] [Related]
4. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic avenues for γδ T cells in cancer.
Costa GP; Mensurado S; Silva-Santos B
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
[TBL] [Abstract][Full Text] [Related]
6. γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y; Hu Q; Li Y; Lu L; Xiang Z; Yin Z; Kabelitz D; Wu Y
Signal Transduct Target Ther; 2023 Nov; 8(1):434. PubMed ID: 37989744
[TBL] [Abstract][Full Text] [Related]
7. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG
Front Immunol; 2021; 12():729085. PubMed ID: 34630403
[TBL] [Abstract][Full Text] [Related]
8. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
Liu Y; Zhang C
Cells; 2020 May; 9(5):. PubMed ID: 32413966
[TBL] [Abstract][Full Text] [Related]
9. Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao Y; Niu C; Cui J
J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
[TBL] [Abstract][Full Text] [Related]
10. γδ T cells as a potential therapeutic agent for glioblastoma.
Kang I; Kim Y; Lee HK
Front Immunol; 2023; 14():1273986. PubMed ID: 37928546
[TBL] [Abstract][Full Text] [Related]
11. The emerging roles of γδ T cells in cancer immunotherapy.
Mensurado S; Blanco-Domínguez R; Silva-Santos B
Nat Rev Clin Oncol; 2023 Mar; 20(3):178-191. PubMed ID: 36624304
[TBL] [Abstract][Full Text] [Related]
12. γδ T cells: Major advances in basic and clinical research in tumor immunotherapy.
Zhao Y; Dong P; He W; Zhang J; Chen H
Chin Med J (Engl); 2024 Jan; 137(1):21-33. PubMed ID: 37592858
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
Miyashita M; Shimizu T; Ashihara E; Ukimura O
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
[TBL] [Abstract][Full Text] [Related]
14. The capability of heterogeneous γδ T cells in cancer treatment.
Yan W; Dunmall LSC; Lemoine NR; Wang Y; Wang Y; Wang P
Front Immunol; 2023; 14():1285801. PubMed ID: 38077392
[TBL] [Abstract][Full Text] [Related]
15. Gamma/delta T cells as cellular vehicles for anti-tumor immunity.
Wang CQ; Lim PY; Tan AH
Front Immunol; 2023; 14():1282758. PubMed ID: 38274800
[TBL] [Abstract][Full Text] [Related]
16. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
[TBL] [Abstract][Full Text] [Related]
17. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
Ma R; Yuan D; Guo Y; Yan R; Li K
Front Immunol; 2020; 11():1600. PubMed ID: 33013819
[TBL] [Abstract][Full Text] [Related]
18. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
Reyes RM; Deng Y; Zhang D; Ji N; Mukherjee N; Wheeler K; Gupta HB; Padron AS; Kancharla A; Zhang C; Garcia M; Kornepati AVR; Boyman O; Conejo-Garcia JR; Svatek RS; Curiel TJ
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849925
[TBL] [Abstract][Full Text] [Related]
19. Transient 40 °C-shock potentiates cytotoxic responses of Vδ2
Lin L; Chen Y; Chen D; Shu J; Hu Y; Yin Z; Wu Y
Cancer Immunol Immunother; 2022 Oct; 71(10):2391-2404. PubMed ID: 35195762
[TBL] [Abstract][Full Text] [Related]
20. Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy.
Bartish M; Del Rincón SV; Rudd CE; Saragovi HU
Front Immunol; 2020; 11():564499. PubMed ID: 33133075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
